HDAC inhibitors as epigenetic regulators for cancer immunotherapy

M Conte, R De Palma, L Altucci - The international journal of biochemistry & …, 2018 - Elsevier
In recent years, anti-tumor immunotherapy has shown promising results, and immune-
oncology is now emerging as the fourth major wave in the treatment of tumors after …
被引用次数：75 相关文章

HDAC inhibitors as epigenetic regulators for cancer immunotherapy

M Conte, R De Palma, L Altucci - … OF BIOCHEMISTRY & CELL …, 2018 - iris.unicampania.it
In recent years, anti-tumor immunotherapy has shown promising results, and immune-
oncology is now emerging as the fourth major wave in the treatment of tumors after …

[引用][C] HDAC inhibitors as epigenetic regulators for cancer immunotherapy

M Conte, R De Palma, L Altucci - … Journal of Biochemistry & Cell Biology, 2018 - cir.nii.ac.jp
HDAC inhibitors as epigenetic regulators for cancer immunotherapy | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

HDAC inhibitors as epigenetic regulators for cancer immunotherapy

M Conte, R De Palma, L Altucci - … international journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
In recent years, anti-tumor immunotherapy has shown promising results, and immune-
oncology is now emerging as the fourth major wave in the treatment of tumors after …

HDAC inhibitors as epigenetic regulators for cancer immunotherapy.

M Conte, R De Palma, L Altucci - The International Journal of …, 2018 - europepmc.org
In recent years, anti-tumor immunotherapy has shown promising results, and immune-
oncology is now emerging as the fourth major wave in the treatment of tumors after …

[引用][C] HDAC inhibitors as epigenetic regulators for cancer immunotherapy

M Conte, R De Palma, L Altucci - 2018